Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (137)
  • 2024 (206)
  • 2023 (241)
  • 2022 (286)
  • 2021 (101)
  • 2020 (21)
  • 2019 (3)
  • 2018 (10)

Subject

  • Drug Trafficking (4013)
  • Synthetic drugs (1065)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Guns/Weapons (990)
  • Congressional Affairs (15)

Drug Name

  • Fentanyl (468)
  • Cocaine (414)
  • Methamphetamine (375)
  • Heroin (229)
  • Marijuana (Cannabis) (90)
  • Oxycodone (25)
  • Synthetic Opioids (22)
  • Ecstasy/MDMA (16)
  • Opioids (6)
  • Ketamine (4)
  • Psilocybin (3)
  • K2/Spice (2)
  • LSD (2)
  • Amphetamines (1)
  • Marijuana Concentrates (1)
  • Steroids (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • New England (273)
  • St. Louis (115)
  • Chicago (113)
  • Washington, DC (95)
  • Seattle (87)
  • New York (74)
  • El Paso (41)
  • New Jersey (34)
  • Miami (31)
  • San Francisco (27)
  • Atlanta (25)
  • Dallas (21)
  • Sede (20)
  • Phoenix (12)
  • Houston (9)
  • Los Angeles (6)
  • New Orleans (5)
  • Louisville (4)
  • Omaha (4)
  • Rocky Mountain (4)
  • San Diego (3)
  • Detroit (2)
Clear All Results
PRESS RELEASE

24 defendants charged in joint federal and state investigation of two violent street gangs on the West Side of Chicago

Junio 26, 2020
CHICAGO -- Twenty-four individuals are facing federal charges following an investigation targeting two street gangs responsible for firearms offenses, narcotics trafficking, and violence on the West Side of Chicago. During the investigation, dubbed “Operation Full Circle,” federal, state, and local law enforcement officers worked together to seize 34 firearms, more...
Junio 26, 2020
PRESS RELEASE

Mexican national pleads guilty to drug conspiracy and gun offenses

Junio 12, 2020
FRESNO, Calif. — Javier Ochoa-Anaya, 49, residing in Denair, California pled guilty today to conspiracy to distribute methamphetamine and possessing firearms in furtherance of drug trafficking offenses, U.S. Attorney McGregor W. Scott and Drug Enforcement Administration Special Agent in Charge Daniel C. Comeaux announced. According to the plea agreement, Ochoa...
Junio 12, 2020
PRESS RELEASE

Fentanyl and heroin darknet vendors indicted

Abril 05, 2019
SACRAMENTO, Calif. — A Rancho Cordova woman was indicted on April 4, 2019, charged with distribution of fentanyl and oxycodone and other opioids as a result of a coordinated operation by the U.S. Attorney’s Office, the Federal Bureau of Investigation, Homeland Security Investigations, the Drug Enforcement Administration and the U.S...
Abril 05, 2019
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

Febrero 26, 2019
WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
Febrero 26, 2019
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

Febrero 07, 2019
NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
Febrero 07, 2019
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

Noviembre 02, 2018
WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
Noviembre 02, 2018
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

Agosto 31, 2018
WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
Agosto 31, 2018
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

Agosto 28, 2018
CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
Agosto 28, 2018
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

Agosto 16, 2018
WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...
Agosto 16, 2018
PRESS RELEASE

Department of Justice announces regulatory steps to address opioid epidemic

Julio 11, 2018
WASHINGTON – The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication...
Julio 11, 2018
Showing 991 - 1000 of 1005 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 93
  • Página 94
  • Página 95
  • Página 96
  • Página 97
  • Página 98
  • Página 99
  • Current page 100
  • Página 101
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster